Auteurs Giuliano S, Ohanna M, Ballotti R, Bertolotto C
Pigment cell & melanoma research Apr 2011
Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle.Auteurs Ohanna M, Bertolotto C, Ballotti R
Pigment cell & melanoma research Feb 2011
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.Auteurs Fenouille N, Puissant A, Dufies M, Robert G, Jacquel A, Ohanna M, Deckert M, Pasquet JM, Mahon FX, Cassuto JP, Raynaud S, Tartare-Deckert S, Auberger P
Cancer research Dec 2010
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.Auteurs Fenouille N, Robert G, Tichet M, Puissant A, Dufies M, Rocchi S, Ortonne JP, Deckert M, Ballotti R, Tartare-Deckert S
Pigment cell & melanoma research Nov 2010
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth.Auteurs Botton T, Puissant A, Cheli Y, Tomic T, Giuliano S, Fajas L, Deckert M, Ortonne JP, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S
Cell death and differentiation Juil 2010
Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.Auteurs Giuliano S, Cheli Y, Ohanna M, Bonet C, Beuret L, Bille K, Loubat A, Hofman V, Hofman P, Ponzio G, Bahadoran P, Ballotti R, Bertolotto C
Cancer research May 2010
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.Auteurs Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C, Deckert M, Auberger P, Tanti JF, Bost F
Cancer research Mar 2010
Fifteen-year quest for microphthalmia-associated transcription factor target genes.Auteurs Cheli Y, Ohanna M, Ballotti R, Bertolotto C
Pigment cell & melanoma research Feb 2010
The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.Auteurs Marchetti S, Gamas P, Belhacène N, Grosso S, Pradelli LA, Colosetti P, Johansen C, Iversen L, Deckert M, Luciano F, Hofman P, Ortonne N, Khemis A, Mari B, Ortonne JP, Ricci JE, Auberger P
The EMBO journal Aug 2009
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors.Auteurs Grosso S, Puissant A, Dufies M, Colosetti P, Jacquel A, Lebrigand K, Barbry P, Deckert M, Cassuto JP, Mari B, Auberger P
Molecular cancer therapeutics Jul 2009